As of April 2024 Nektar Therapeutics has a market cap of $0.24 Billion. This makes Nektar Therapeutics the world's 6741th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.24 B | 124.87% |
2023 | $0.10 B | -74.63% |
2022 | $0.42 B | -82.96% |
2021 | $2.49 B | -18.24% |
2020 | $3.04 B | -19.95% |
2019 | $3.80 B | -33.21% |
2018 | $5.70 B | -39.35% |
2017 | $9.40 B | 401.47% |
2016 | $1.87 B | -17.74% |
2015 | $2.27 B | 12.08% |
2014 | $2.03 B | 53.82% |
2013 | $1.32 B | 54.81% |
2012 | $0.85 B | 33.4% |
2011 | $0.64 B | -47.29% |
2010 | $1.21 B | 39.7% |
2009 | $0.86 B | 69.14% |
2008 | $0.51 B | -17.01% |
2007 | $0.61 B | -55.39% |
2006 | $1.38 B | -3.83% |
2005 | $1.44 B | -15.66% |
2004 | $1.71 B | 123.8% |
2003 | $0.76 B | 70.39% |
2002 | $0.44 B | -56.08% |
2001 | $1.02 B |
On Apr 24th, 2024 the market cap of Nektar Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $353.80 B | 145,873.30% | ๐บ๐ธ USA |
Pfizer PFE | $143.03 B | 58,914.05% | ๐บ๐ธ USA |
Amgen AMGN | $144.48 B | 59,513.62% | ๐บ๐ธ USA |
Baxter BAX | $20.49 B | 8,354.24% | ๐บ๐ธ USA |
Merck MRK | $331.11 B | 136,513.35% | ๐บ๐ธ USA |
AstraZeneca AZN | $232.62 B | 95,877.42% | ๐ฌ๐ง UK |
Richardson Electronics RELL | $0.14 B | -41.33% | ๐บ๐ธ USA |
Alkermes ALKS | $4.13 B | 1,605.97% | ๐ฎ๐ช Ireland |